Skip to content

Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity

A Prospective, Non-interventional, Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01387074
Enrollment
108
Registered
2011-07-04
Start date
2011-06-30
Completion date
2013-01-31
Last updated
2014-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Spasticity

Brief summary

This is a prospective, non-interventional, observational study to collect data on the use of botulinum toxin Type A in a routine setting in patients with upper limb adult spasticity.

Interventions

BIOLOGICALbotulinum toxin Type A

Botulinum toxin Type A treatment at a dose determined by the physician at Baseline followed by a second botulinum toxin Type A treatment approximately 12 weeks later if applicable.

Sponsors

Allergan
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients with upper limb spasticity following a stroke * Eligible to receive botulinum toxin Type A * No previous botulinum toxin Type A therapy

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at BaselineBaselineThe MAS assessed the degree of muscle tone during movement of the elbow compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.
Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Week 24Week 24The MAS assessed the degree of muscle tone during movement of the elbow compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.
Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at BaselineBaselineThe MAS assessed the degree of muscle tone during movement of the wrist compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.
Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at Week 24Week 24The MAS assessed the degree of muscle tone during movement of the wrist compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.
Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at BaselineBaselineThe MAS assessed the degree of muscle tone during movement of the fingers compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.
Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at Week 24Week 24The MAS assessed the degree of muscle tone during movement of the fingers compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.
Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at BaselineBaselineThe MAS assessed the degree of muscle tone during movement of the thumb compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.
Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at Week 24Week 24The MAS assessed the degree of muscle tone during movement of the thumb compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.

Countries

Germany

Participant flow

Participants by arm

ArmCount
Botulinum Toxin Type A
Botulinum toxin Type A treatment at a dose determined by the physician at Baseline followed by a second botulinum toxin Type A treatment approximately 12 weeks later if applicable.
108
Total108

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLack of Efficacy1
Overall StudyLost to Follow-up7

Baseline characteristics

CharacteristicBotulinum Toxin Type A
Age, Customized
18-30 Years
8 Participants
Age, Customized
31-40 Years
13 Participants
Age, Customized
41-50 Years
22 Participants
Age, Customized
51-60 Years
23 Participants
Age, Customized
61-70 Years
24 Participants
Age, Customized
71-80 Years
14 Participants
Age, Customized
81-90 Years
4 Participants
Sex: Female, Male
Female
47 Participants
Sex: Female, Male
Male
61 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 108
serious
Total, serious adverse events
1 / 108

Outcome results

Primary

Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Baseline

The MAS assessed the degree of muscle tone during movement of the elbow compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.

Time frame: Baseline

Population: Efficacy population included all participants who received BOTOX® not previously treated with botulinum toxin.

ArmMeasureGroupValue (NUMBER)
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Baseline0=No Increase2 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Baseline1=Slight Increase6 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Baseline1+=Slight Increase18 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Baseline2=Marked Increase39 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Baseline3=Considerable Increase30 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Baseline4=Affected part rigid6 Participants
Primary

Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Week 24

The MAS assessed the degree of muscle tone during movement of the elbow compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.

Time frame: Week 24

Population: Participants from the Efficacy population (all participants who received BOTOX® not previously treated with botulinum toxin) who had data available for this outcome measure.

ArmMeasureGroupValue (NUMBER)
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Week 240=No Increase2 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Week 241=Slight Increase26 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Week 241+=Slight Increase43 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Week 242=Marked Increase12 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Week 243=Considerable Increase5 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Week 244=Affected part rigid1 Participants
Primary

Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at Baseline

The MAS assessed the degree of muscle tone during movement of the fingers compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.

Time frame: Baseline

Population: Efficacy population included all participants who received BOTOX® not previously treated with botulinum toxin.

ArmMeasureGroupValue (NUMBER)
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at Baseline0=No Increase0 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at Baseline1=Slight Increase5 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at Baseline1+=Slight Increase15 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at Baseline2=Marked Increase20 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at Baseline3=Considerable Increase47 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at Baseline4=Affected part rigid14 Participants
Primary

Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at Week 24

The MAS assessed the degree of muscle tone during movement of the fingers compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.

Time frame: Week 24

Population: Participants from the Efficacy population (all participants who received BOTOX® not previously treated with botulinum toxin) who had data available for this outcome measure.

ArmMeasureGroupValue (NUMBER)
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at Week 240=No Increase4 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at Week 241=Slight Increase34 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at Week 241+=Slight Increase27 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at Week 242=Marked Increase17 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at Week 243=Considerable Increase5 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Fingers at Week 244=Affected part rigid2 Participants
Primary

Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at Baseline

The MAS assessed the degree of muscle tone during movement of the thumb compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.

Time frame: Baseline

Population: Efficacy population included all participants who received BOTOX® not previously treated with botulinum toxin.

ArmMeasureGroupValue (NUMBER)
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at Baseline0=No Increase1 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at Baseline1=Slight Increase13 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at Baseline1+=Slight Increase19 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at Baseline2=Marked Increase19 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at Baseline3=Considerable Increase36 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at Baseline4=Affected part rigid13 Participants
Primary

Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at Week 24

The MAS assessed the degree of muscle tone during movement of the thumb compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.

Time frame: Week 24

Population: Participants from the Efficacy population (all participants who received BOTOX® not previously treated with botulinum toxin) who had data available for this outcome measure.

ArmMeasureGroupValue (NUMBER)
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at Week 240=No Increase19 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at Week 241=Slight Increase29 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at Week 241+=Slight Increase18 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at Week 242=Marked Increase11 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at Week 243=Considerable Increase11 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Thumb at Week 244=Affected part rigid1 Participants
Primary

Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at Baseline

The MAS assessed the degree of muscle tone during movement of the wrist compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.

Time frame: Baseline

Population: Efficacy population included all participants who received BOTOX® not previously treated with botulinum toxin.

ArmMeasureGroupValue (NUMBER)
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at Baseline0=No Increase3 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at Baseline1=Slight Increase9 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at Baseline1+=Slight Increase16 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at Baseline2=Marked Increase29 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at Baseline3=Considerable Increase35 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at Baseline4=Affected part rigid9 Participants
Primary

Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at Week 24

The MAS assessed the degree of muscle tone during movement of the wrist compared to normal muscle tone using a 6-point scale where: 0=no increase in muscle tone, 1=Slight increase in muscle tone manifested by a catch and release or by minimal resistance at the end of the range of motion when the part is moved, 1+=Slight increase in muscle tone manifested by a catch followed by minimal resistance throughout the remainder of the range of motion, 2=Marked increase in muscle tone through most of the range of motion but affected part easily moved, 3=Considerable increase in muscle tone passive movement difficult or 4=Affected part rigid in movement or extension. A low score indicated little or no stiffness (best). A high score indicated severe stiffness (worse). The number of participants in each score category is presented.

Time frame: Week 24

Population: Participants from the Efficacy population (all participants who received BOTOX® not previously treated with botulinum toxin) who had data available for this outcome measure.

ArmMeasureGroupValue (NUMBER)
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at Week 240=No Increase5 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at Week 241=Slight Increase31 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at Week 241+=Slight Increase31 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at Week 242=Marked Increase15 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at Week 243=Considerable Increase6 Participants
Botulinum Toxin Type AMuscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Wrist at Week 244=Affected part rigid1 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026